ELDN icon

Eledon Pharmaceuticals
ELDN

Overview Fund Activity

44 hedge funds and large institutions have $4.21M invested in Eledon Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
-4
Holders Change %
-8.33%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
12
Reduced
10
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
Bridgeway Capital Management
Texas
$693K
2
Renaissance Technologies
Renaissance Technologies
New York
$330K
3
EA
Emerald Acquisition
Washington
$150K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$111K
5
BFA
BlackRock Fund Advisors
California
$905K

Top Sellers

1
PA
Perceptive Advisors
New York
$0
2
Fidelity Investments
Fidelity Investments
Massachusetts
$0
3
SAM
Senzar Asset Management
New York
$0
4
Franklin Resources
Franklin Resources
California
$0
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PAM
51
Paradigm Asset Management
New York
– -$97K -109 Closed
CS
52
Credit Suisse
Switzerland
– -$72K -80 Closed
Creative Planning
53
Creative Planning
Kansas
– -$18K -20 Closed
BJ
54
BlackRock Japan
Japan
– -$10K -11 Closed
1 2
3